Increased noninvasive cardiac testing (NICT) does not lower the risk for major adverse cardiac events (MACE) within 2 years of emergency visit in patients presenting with chest pain but no acute ...
KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc. today announces that Atlas Genomics, Prevencio’s performing laboratory for its Artificial Intelligence (AI)-driven cardiac HART blood tests, has ...